Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Synucure Therapeutics Logo
Synucure Therapeutics Growth Score
63
CB Rank
125390
Heat Score
35
Synucure Therapeutics is a Canadian biotechnology business that operates research on degenerative brain illnesses.
Founded
obfuscation
PrivateSeed Montréal, Quebec, Canada1-10 synucure.com
Biotechnology
Health Care
Overview

Synucure Therapeutics
Total Funding
obfuscation
Growth Score
63
Heat Score
35

Total Funding
obfuscation
obfuscation
Seed raised
obfuscation
Growth Score63
-5 pts
in past quarter
Heat Score 35
-18 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Synucure Therapeutics

CB Rank
125390
Synucure Therapeutics is a Canadian biotechnology business that operates research on degenerative brain illnesses.
Founded
obfuscation
PrivateSeed Montréal, Quebec, Canada1-10 synucure.com
Biotechnology
Health Care

Funding Rounds

Seed
OBF
in
obfuscation

Key People

Details

Legal Name Synucure Therapeutics Inc.
Operating Status Active
Company Type For Profit
Founders  Francesca Cicchetti, Louis Tremblay, Sylvain Chrétien
About the Company
Synucure Therapeutics is a Canadian biotechnology business that operates research on degenerative brain illnesses.
Predictions & Insights

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Runway Speculation

Products & Services

SYN-001
A novel formulation of Cysteamine designed as a disease-modifying therapy to halt or reverse Parkinson’s disease progression.
Proprietary Blood Biomarkers for Parkinson’s Disease
Patented blood biomarkers developed to provide clinicians with a rapid and precise diagnostic tool for Parkinson’s disease via a simple blood test.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - Synucure Therapeutics Logo
Seed Round - Synucure Therapeutics
1
obfuscation
Investissement QuebecSeed
obfuscation
Seed Round - Synucure Therapeutics Logo
Seed Round - Synucure Therapeutics
1
obfuscation
Investissement QuebecSeed
obfuscation
Seed Round - Synucure Therapeutics Logo
Seed Round - Synucure Therapeutics
1
obfuscation
Investissement QuebecSeed
obfuscation
Seed Round - Synucure Therapeutics Logo
Seed Round - Synucure Therapeutics
1
obfuscation
Investissement QuebecSeed
obfuscation
Seed Round - Synucure Therapeutics Logo
Seed Round - Synucure Therapeutics
1
obfuscation
Investissement QuebecSeed

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - Synucure Therapeutics Logo
Seed Round - Synucure Therapeutics
1
obfuscation
Investissement QuebecSeed
obfuscation
Seed Round - Synucure Therapeutics Logo
Seed Round - Synucure Therapeutics
1
obfuscation
Investissement QuebecSeed
obfuscation
Seed Round - Synucure Therapeutics Logo
Seed Round - Synucure Therapeutics
1
obfuscation
Investissement QuebecSeed
obfuscation
Seed Round - Synucure Therapeutics Logo
Seed Round - Synucure Therapeutics
1
obfuscation
Investissement QuebecSeed
obfuscation
Seed Round - Synucure Therapeutics Logo
Seed Round - Synucure Therapeutics
1
obfuscation
Investissement QuebecSeed

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 3

Employee Profiles

News
Technology
View Tech Report

Monthly Web Visits

219
56.43%
 in past month

Active Website Tech Count

7Synucure Therapeutics is actively using 7 technologies for its website, according to BuiltWith. These include CommonCrawl Top 50m, HSTS, and  LetsEncrypt.
Sub-Organizations
Frequently Asked Questions

Where is Synucure Therapeutics's headquarters? Synucure Therapeutics is located in Montréal, Quebec, Canada.Who invested in Synucure Therapeutics? Synucure Therapeutics is funded by Investissement Quebec.When was the last funding round for Synucure Therapeutics? Synucure Therapeutics closed its last funding round on
obfuscation
from a Seed round.Who are Synucure Therapeutics's competitors? Alternatives and possible competitors to Synucure Therapeutics may include AbbVie, Michael J. Fox Foundation, and  Roche.How much funding has Synucure Therapeutics raised to date? Synucure Therapeutics has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(d29fb2e 1)
|